These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11014962)

  • 1. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
    Mischke R; Wolling H
    Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-stage prothrombin time, activated partial thromboplastin time, thrombin time, fibrin degradation product concentration, and antithrombin activity in healthy adult alpacas.
    House AM; Barton MH; Williamson LH
    Vet Clin Pathol; 2011 Jun; 40(2):195-7. PubMed ID: 21554362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anticoagulant activities of isolated canine fibrinogen degradation products X, Y, D and E using resonance thrombography.
    Mischke R; Wolling H; Nolte I
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):81-8. PubMed ID: 15166948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for shortening PT and APTT in dogs and rats--effect of fibrinogen on PT and APTT--.
    Kurata M; Sasayama Y; Yamasaki N; Kitazawa I; Hamada Y; Horii I
    J Toxicol Sci; 2003 Dec; 28(5):439-43. PubMed ID: 14746347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.
    Kanda GS; Ho WK; Rodrigues C; Bousounis A; Hogan C
    Pathology; 2021 Aug; 53(5):623-627. PubMed ID: 33526243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
    Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
    Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of fructose diphosphate on routine coagulation tests in vitro.
    Chen T; Chen D; Chen L; Chen Z; Wang B; Zhou D
    Sci Rep; 2022 Jan; 12(1):304. PubMed ID: 34997135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of telavancin (Vibativ) on routine coagulation test results.
    Gosselin R; Dager W; Roberts A; Freeman L; Gandy L; Gregg J; Dwyre D
    Am J Clin Pathol; 2011 Dec; 136(6):848-54. PubMed ID: 22095369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
    Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
    Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
    Rimac V; Coen Herak D
    Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
    Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
    Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D.
    Mischke R; Menzel D; Wolling H
    Haemostasis; 2000; 30(3):131-8. PubMed ID: 11014963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of haemostatic disorders in experimentally induced leishmaniasis in Beagle dogs.
    Valladares JE; Ruiz De Gopegui R; Riera C; Alberola J; Gállego M; Espada Y; Portús M; Arboix M
    Res Vet Sci; 1998; 64(3):195-8. PubMed ID: 9690602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine coagulation molecules predict nasopharyngeal carcinoma and associated metastases.
    Yin J; Zhu SS
    Br J Biomed Sci; 2019 Oct; 76(4):178-183. PubMed ID: 31210089
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
    Morishima Y; Kamisato C
    Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of glutathione on blood coagulation function].
    Chen TQ; Chen CC; Wang JX; Chen WF; Gu XM; Xu RS; Li ZX; Wu DX; Zhang WS; Zhao Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1612-6. PubMed ID: 24370058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
    Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
    Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.